SURG NEWS: SURGE HOLDINGS NAMES ANTHONY P. NUZZO PRESIDENT

New Post Public Reply Private Reply Replies (0) Message Board
trooperstocks
214
SURG NEWS: SURGE HOLDINGS NAMES ANTHONY P. NUZZO PRESIDENT AND CHIEF OPERATING OFFICER

The Board of Directors has Unanimously Appointed Anthony P. Nuzzo, Jr. President and COO to oversee multi-national operations as part of the Company’s plans for expansion and 2019 product rollout.

Memphis, TN, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Surge Holdings, Inc. (OTCQB: SURG), the Memphis-based Technology, Telecom and Blockchain FinTech Software Company is pleased to announce that the Company’s Board of Directors has unanimously appointed Anthony P. Nuzzo, Jr. as President and Chief Operating Officer to oversee the Surge Holdings multi-national operations. Mr. Nuzzo is a proven leader with a track record of delivering results. The Board is confident in Mr. Nuzzo’s ability to execute on the Company’s strategic plans, preside over an expanding workforce and scale the organization appropriately.

Anthony P. Nuzzo, President and Chief Operating Office stated; “I have been involved in organizing and scaling several companies in my career and have an extremely successful track record including the status achieved on Inc. Magazine 500 Fastest Growing Institutions, but I have never seen an opportunity for growth this exciting and this significant. I am honored to accept the position of President of Surge Holdings, Inc. and look forward to ensuring a best in class organization that puts our customers and our shareholders first improving shareholder value. Surge is poised for massive growth in 2019 and I am confident in my ability to provide the organizational structure and financial planning for Surge to execute on our vision. I am also so proud of our mission to enhance people’s lives through delivering technology and a better standard of service. Surge provides industry-changing technology that already makes a difference for so many.“

Mr. Nuzzo is an experienced operations officer and entrepreneur who has owned and operated accounting services and accounts receivable companies since 1991. Mr. Nuzzo brings decades of operational and business experience and excels as a financial manager expert in all facets of accounting, controls and scaling operations. Mr. Nuzzo has been honored by Inc. 500 Fastest Growing Private Companies on numerous occasions.

Brian Cox, CEO of SURG, said “We at Surge are fortunate to have the abilities of Anthony Nuzzo leading our team. His skills in operational planning, financial management and implementing best practices will provide the structure and controls for strong and sustainable growth. The trust I have in him and his ability allows me to focus on up-listing to NASDAQ, product development, vendor relationships, evaluating acquisitions and strategic partnerships, and doing the things necessary to enhance shareholder value by getting the Surge story out to the masses. Ultimately, this is a key component in achieving our 2019 goals.“



About Surge Holdings:

Surge Holdings a publicly traded company that wholly owns and actively operated subsidiaries that utilize emerging technology to improve the quality of life for the unbanked, under-banked, and the overlooked. Current holdings include Telecommunications, Blockchain Fintech Software as a Service (SaaS), Global BPO and Social Media Digital Marketing. Surge Holdings, Inc is traded under the stock ticker symbol: SURG.


To get the SURGE shareholder guide and the latest news: https://surgeholdings.com

SurgePhone Wireless service can be ordered online: https://surgephone.com

Follow Surge Holdings on Twitter: https://twitter.com/surgeholdings

Follow CEO Brian Cox on Twitter for thoughts, insight, and progress of not only the short-term goals prioritized in this update, but relevant and material news for Surge: https://twitter.com/kbriancox



FORWARD LOOKING STATEMENTS


This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the U.S. Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.


Invest@SurgeHoldings.com
901-229-7205

SurgePays Inc. (SURGD) Stock Research Links

SURGD Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 119

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 50

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 56

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 84

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

Equitage Ventures Launches $47.3M Fund for Senior Care Tech

Updated Category News Views 329

Equitage Ventures Launches Significant Investment Fund Equitage Ventures, an early-stage venture capital firm dedicated to AgeTech, has announced the successful final closing of a substantial $47.3 million investment fund. This fund is designed to provide critical capital, distribution resources, and strategic guidance to innovative entrepreneurs who aim to tackle the...

Continue Reading
Understanding Market Trends: Insights into Chevron Corp's Performance

Updated Category News Views 171

Chevron Corp Market Sentiment Analysis Chevron Corp (NYSE: CVX) has experienced a noteworthy decline in its short interest as a percentage of float, showing a 10.26% decrease since its previous report. Currently, there are approximately 14.02 million shares sold short, which accounts for 0.7% of all shares available for trading. Given the trading volume, it is estimated...

Continue Reading
Establishment of Blakely McCrory Hope Fund at Moody Gardens

Updated Category News Views 200

Introducing the Blakely McCrory Hope Fund Moody Gardens is proud to announce a special initiative to honor the memory of a young girl who captured the hearts of many: the Blakely McCrory Hope Fund. This fund has been established in loving memory of 8-year-old Blakely McCrory, who lost her life in a tragic flooding incident that occurred during the summer months....

Continue Reading
Star-Studded Table Read of 'It's a Wonderful Life' Event

Updated Category News Views 221

Exciting Holiday Table Read for a Worthy Cause The Ed Asner Family Center is pulling out all the stops this holiday season with an exciting virtual table read of the beloved classic, "It's a Wonderful Life." Scheduled for December 14 at 5 PM PST, this event promises to spread joy while supporting individuals and families with special needs. Star-Studded Cast Comes...

Continue Reading
Transforming $100 Into Over $1700 with Monolithic Power Systems

Updated Category News Views 145

Understanding the Growth of Monolithic Power Systems Monolithic Power Systems (NASDAQ: MPWR) has showcased impressive financial performance over the past decade, outperforming many market benchmarks. With an impressive annualized growth rate of 19.88%, it has attracted the attention of savvy investors. The Power of Compounded Returns Imagine investing $100 in MPWR stock...

Continue Reading